Journal of controlled release : official journal of the Controlled Release Society

Lipid nanoparticles using one molecule to deliver therapeutic mRNA to brain tumors across the blood-brain barrier

Updated

Abstract

Mannose-cholesterol LNPs achieve 9.9-fold greater brain accumulation than non-targeted formulations in healthy mice.

  • GLUT1 is a potential target for delivering mRNA to brain tumors due to its abundance on brain blood vessels and overexpression in glioblastoma.
  • High ligand densities on LNPs are necessary for effective GLUT1 engagement but are difficult to achieve with conventional methods.
  • Mannose-cholesterol conjugation allows for ~30 mol% surface ligand density without compromising mRNA encapsulation.
  • Functional delivery of Cre mRNA using MC_LNPs shows expression in neurons and astrocytes in Ai14 reporter mice.
  • In glioblastoma models, mRNA-loaded MC_LNPs reduce tumor burden by 6-fold and extend median survival from 33 to 49 days.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

No financial or personal ties reported.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free